King's College London

King's College Londonis academic base for the LEAP Study is King’s College London. Professor Lack and his team are part of the Division of Asthma, Allergy & Lung Biology in the School of Medicine.

King's College, London is the fourth oldest university in England with more than 13,700 undergraduates and nearly 5,600 graduate students in nine schools of study based at five London campuses. It is a member of the Russell Group: a coalition of the UK's major research-based universities. The College has had 24 of its subject-areas awarded the highest rating of 5* and 5 for research quality, demonstrating excellence at an international level, and it has recently received an excellent result in its audit by the Quality Assurance Agency.

King's has a particularly distinguished reputation in the humanities, law, international relations, medicine, nursing and the sciences, and has played a major role in many of the advances that have shaped modern life, such as the discovery of the structure of DNA. It is the largest centre for the education of healthcare professionals in Europe and is home to four Medical Research Council Centres – more than any other university.

King's is in the top group of UK universities for research earnings, with income from grants and contracts of more than £100 million, and has an annual turnover of more than £363 million. 

MRC-Asthma UK Centre in Allergic Mechanisms of Asthma

MRC-Asthma UK Centre in Allergic Mechanisms of Asthma was set up in 2005 to tackle severe asthma caused by allergies. The Centre provides excellent prospects for disease prevention and control. It is a partnership between the MRC, Asthma UK, Imperial College London, King's College London and partner NHS Trusts.

[top]